Drawing for BENEVI

USPTO serial 86793518

BENEVI

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KON, ELISSA GARBER
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BENEVI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Devon E. White

DEVON E. WHITE Wyrick Robbins Yates & Ponton Llp4101 Lake Boone Trl Ste 300Raleigh, NC 27607-7525UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035mail order services in the field of prescription drugs, biologics/biotechnology goods, and medical devices; mail order pharmacy services; business management of reimbursement programs; Business services, namely, reimbursement reporting in the field of prescription drugs, biologics/biotechnology goods, and medical devices; Managed care services, namely, utilization review and pre-certification services; Evidenced-based health care cost management services and healthcare utilization and review services; Retail pharmacy services, namely, coordinating filling and refilling prescriptions, generating reports to patients, prescribers, and care givers regarding prescriptions, and assisting with pharmaceutical drug billing; Pharmaceutical distributorship services; Retail pharmacy distribution services featuring a patient assistance program; Retail pharmacy services featuring free starter drug programs; Pharmaceutical cost management advisory, reimbursement management, and consulting services and drug utilization review advisory and consulting services; Business consulting and management in the field of clinical trials, namely clinical trial supply and material logistical management; Business consulting and management, namely, clinical trial drug logistics and distribution; Providing comprehensive management services to pharmaceutical companies, namely, business management services for benefit eligibility services, prior authorization of medical and pharmacy services, 24 hour nurse care managers services; Patient assistance program, namely, providing business and cost management information regarding drug cost reimbursement and providing billing assistance and free drug distribution; Specialty care management and prescription services, namely, specialty pharmacy services and arranging of managed care contractual services in the fields of specialty pharmacy services; business administration of a regulatory compliance medication enrollment program in the field of prescription medicine by maintaining a risk evaluation and mitigation strategy registry and providing record keeping services to ensure the proper prescribing and dispensing of pharmaceuticals for physicians, pharmacists and patients; distributorship services in the field of pharmaceuticals; business management of personalized wellness and healthcare care programs to specialty care and non-specialty care members, through member healthcare management provided by specialized cliniciansACTIVE—
044Providing medical record analysis and assessments that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns; Patient medication care management, nursing and medication adherence services, namely, communicating with patients regarding their medications, adherence to medication regimens, medication side-effects, allergic sensitivity, drug interactions, or other issues related to medication tolerance, alternate medication brands or generics, dosage or manner of taking medications; Health care services, namely, providing information to physicians, health care professionals and patients on the topic of health issues and health awareness; patient assistance program to provide drugs and medical services at a reduced cost to low-income patients without prescription drug coverage or health insurance coverage; Specialty care management services, namely, providing wellness services in the nature of personal health assessments; Comprehensive health care services in the field of chronic illnesses; healthcare services, namely, disease management programs for chronically ill persons; health risk assessment services; providing personalized healthcare and wellness programs to specialty care and non-specialty care members, that feature member healthcare management provided by specialized clinicians; providing medical and health care related information about prescription drugs as it relates to the misuse risk evaluation and mitigation strategies for prescription drugs and facilitating the exchange of information between patients and drug prescribersACTIVE—
045providing patient advocate and case management services, namely, the coordination of necessary medical services for persons with medical conditions requiring specialized care or resulting from catastrophic events; regulatory compliance consulting and related information for prescription drugs in the nature of providing information on misuse risk evaluation and mitigation strategies for prescription drugs and facilitating the exchange of information between patients and drug prescribersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 19, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 19, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 15, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 20, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 20, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 31, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 10, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 10, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Aug 10, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 10, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 10, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 9, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 8, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 8, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 11, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2016DOCKASSIGNED TO EXAMINER—
Oct 23, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 23, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance